Published online Sep 28, 2020. doi: 10.35713/aic.v1.i3.45
Peer-review started: July 22, 2020
First decision: September 13, 2020
Revised: September 18, 2020
Accepted: September 23, 2020
Article in press: September 23, 2020
Published online: September 28, 2020
This editorial will focus on and discuss growing artificial intelligence (AI) and the utilization of AI in human cancer therapy. The databases and big data related to genomes, genes, proteins and molecular networks are rapidly increasing all worldwide where information on human diseases, including cancer and infection resides. To overcome diseases, prevention and therapeutics are being developed with the abundant data analyzed by AI. AI has so much potential for handling considerable data, which requires some orientation and ambition. Appropriate interpretation of AI is essential for understanding disease mechanisms and finding targets for prevention and therapeutics. Collaboration with AI to extract the essence of cancer data and model intelligent networks will be explored. The utilization of AI can provide humans with a predictive future in disease mechanisms and treatment as well as prevention.
Core Tip: The utilization of artificial intelligence (AI) is important for analyzing abundant data on diseases in the big data era. The genomic and molecular data in cancer have been accumulated in databases worldwide. Collaboration with AI in human cancer research is explored in this editorial.